AWS and Bluesight Launch AI for Streamlining Hospital 340B Compliance Processes

AWS (Amazon Web Services) has partnered with Bluesight to introduce Prism, an innovative AI layer designed to enhance hospital pharmacy and compliance data management. The Prism Assistant for ControlCheck has reached general availability, currently operating across 20 health systems, as announced by AWS on October 10, 2025. This initiative aims to simplify the labor-intensive compliance processes associated with the 340B program.

Overview of Prism and Its Functionality

The Prism Assistant is a vital tool that connects various data points within hospital pharmacies, automating what has traditionally been a manual process. According to AWS, a single 340B covered entity can expend over 4,000 staff hours annually just to verify if certain drug purchases qualify for exceptions under compliance rules. The staff must cross-reference numerous data sources, including FDA shortage notices and inventory records, to ensure compliance.

Bluesight's initial product, ControlCheck, assists hospital diversion teams in monitoring controlled substances. However, compliance personnel still had to manually compile reports and analyze data. The introduction of Prism provides a conversational interface that allows users to query ControlCheck data, generate charts, and create reports efficiently.

Future Developments in 340B Compliance Tools

Bluesight is also developing a multi-product agent aimed at enhancing compliance with Group Purchasing Organisation (GPO) regulations, scheduled for release in 2026. This agent will integrate data from Bluesight's suite of products: CostCheck, ShortageCheck, and 340BCheck. These tools collectively will streamline the process of verifying drug purchases and eligibility under federal 340B rules.

Compliance teams face strict regulations that prevent certain hospitals from purchasing outpatient drugs through GPO contracts when alternative channels are available. The upcoming GPO agent will facilitate the documentation of exceptions required by the compliance teams.

Technical Innovations Behind Prism and GPO Agent

The development of Prism was made possible through a rapid three-day engagement between Bluesight engineers and AWS specialists. Utilizing technologies like Amazon Bedrock, the team managed to reduce query latency significantly, from five minutes to just 10 seconds. The architecture also includes features such as chart generation, observability controls, and encryption.

Despite these advancements, AWS emphasizes that the metrics reported are still pending independent verification from the health systems using the tools. Synthetic testing has shown promising results, with a 100% invoice discovery rate and a 93% evidence justification accuracy; however, these figures may not reflect real-world performance.

As Bluesight continues to innovate with AI in compliance processes, the healthcare sector is set to benefit from faster, more accurate data management solutions.